According to a new report published by Allied Market Research, titled, “Surrogacy Market by Type, Technology, and Region: Opportunity Analysis and Industry Forecast, 2016–2025,"The Surrogacy market accounted for $112.80 million in 2016, and is expected to reach $201.40 million by 2025, registering a CAGR of 6.1% from 2016 to 2025.
Surrogacy services are availed by people who are unable to conceive naturally. These services assist infertile couples, single parents, and LGBT community to procreate and start a family. IVF and other assisted reproductive technology (ART) procedures, ICSI, and artificial insemination are some of the widely performed fertility services.
According to the 2018 National Survey on Drug Use and Health (NSDUH), 14.4 million adults aged 18 and older (5.8% of this age group) had alcohol use disorder. This includes 9.2 million men (7.6% of men in this age group) and 5.3 million women. Furthermore, drinking alcohol can reduce both men’s and women’s fertility. Alcohol consumption in men can cause difficulties with fertility, reduced gonadotropin release, testicular atrophy, and decreased testosterone & sperm production. While in women, research shows that even drinking lightly can increase the time it takes to get pregnant and reduce the chances of having a healthy baby. Moreover, women who drink large amounts of alcohol are more likely to have heavy or irregular periods, fertility problems, and can also have effect on ovulation, which can make it difficult to conceive. Furthermore, trend of delayed pregnancy has steadily increased globally.
In older women (more than 40 years), the quality and quantity of a woman's eggs begin to decline with age. In the mid-30s, the rate of follicle loss speeds, resulting in fewer, and poorer quality eggs. This makes conception more difficult and increases the risk of miscarriage. In addition, regular smoking and being overweight or significantly underweight also affect normal ovulation. Estimates from the CDC (2017) further suggest that more women wait until their 30s and 40s to conceive. Aging intending mothers readily opt for fertility treatments such as surrogacy, which supplements the surrogacy market growth
Various factors that lead to infertility include problem with sperm or egg production, age, genetic factors, and excessive exposure to some chemicals and toxins. Furthermore, alcohol consumption, steroid use, surgical removal of one of the testicles due to cancer, and diabetes can also result in low sperm count, thereby leading to infertility problems in men. In women, hormonal disorders, benign growths in uterus, abnormal anatomy of the cervix or uterus, blocked fallopian tubes, stress, chemotherapy, kidney, or sickle cell disease may result in infertility. According to the CDC, nearly 10% women population (approximately 6.1 million) aged between 15 to 44 years face difficulty in getting pregnant in the U.S., thereby stimulating the surrogacy market growth.
By type, the gestational surrogacy segment accounted for the largest surrogacy market share in 2015. This segment is expected to exhibit a prominent growth, owing to some key factors such as higher success rates and rise in prevalence of polycystic ovarian syndrome in women, which leads to difficulty in conceiving a child, resulting in escalated demand for surrogate mothers, thereby leading to surrogacy market growth.
By technology, the IVF (with ICSI) segment accounted for the largest surrogacy market share in 2015. This segment is expected to exhibit a prominent growth rate, owing to some key factors such as higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, and low sperm count.
In addition, Asia-Pacific is expected to experience highest growth rate during the forecast period, majorly owing to surge in adoption of fertility and surrogacy procedures, development in healthcare infrastructure, and rise in fertility tourism.
Key Findings Of The Study
By type, the gestational surrogacy segment held 98% share in the global surrogacy market in 2015.
By technology, the IVF (with ICSI) segment exhibit fastest growth and is expected to grow at a CAGR of 6.3% from 2016 to 2025.
Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 5.2% during the forecast period.